Safety and efficacy of sofosbuvir/velpatasvir in pediatric patients 6 to <18 years old with chronic hepatitis C infection [abstract 748] | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of sofosbuvir/velpatasvir in pediatric patients 6 to <18 years old with chronic hepatitis C infection [abstract 748]

Jonas MM, Romero R, Sokal EM, et al. Safety and efficacy of sofosbuvir/velpatasvir in pediatric patients 6 to <18 years old with chronic hepatitis C infection [abstract 748]. The Liver Meeting. Boston, Massachusetts; 2019.

Publication Type:

Conference Proceedings

Authors:

Jonas, MM; Romero, R; Sokal, EM; et, al

Source:

The Liver Meeting, Boston, Massachusetts (2019)

Cited On:

HCV in Children

Export Citation:

RIS Format

Top